Tags: donald trump | obesity drugs | price | big pharma | maha

Trump's Pharma Takedown: Slashing Obesity Drug Prices to Fuel MAHA's Revolution

(Dreamstime)

By    |   Monday, 08 December 2025 07:23 AM EST

After President Donald Trump's showdown with pharma titans Eli Lilly and Novo Nordisk last month, a seismic shift has unfolded: blockbuster weight-loss drugs like Ozempic and Wegovy, once priced sky-high in America, now match global bargains — unleashing hope for millions trapped by obesity and crushing healthcare bills.

This pact, channeling the "Make America Healthy Again" ethos, unlocks access via Medicare, Medicaid, and the fresh TrumpRx site. As Trump boomed from the Oval Office, "It's going to equalize the world."

© 2025 Newsmax. All rights reserved.


platinum
After President Donald Trump's showdown with pharma titans Eli Lilly and Novo Nordisk last month, a seismic shift has unfolded: blockbuster weight-loss drugs like Ozempic and Wegovy, once priced sky-high in America, now match global bargains.
donald trump, obesity drugs, price, big pharma, maha
1772
2025-23-08
Monday, 08 December 2025 07:23 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
Get Newsmax Text Alerts
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved